A detailed history of Frontier Wealth Management LLC transactions in Humanigen, Inc stock. As of the latest transaction made, Frontier Wealth Management LLC holds 61,000 shares of HGEN stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,000
Previous 61,000 -0.0%
Holding current value
$0
Previous $155,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$1.81 - $3.97 $110,410 - $242,170
61,000 New
61,000 $155,000

Others Institutions Holding HGEN

About HUMANIGEN, INC


  • Ticker HGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,661,000
  • Description
  • Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...
More about HGEN
Track This Portfolio

Track Frontier Wealth Management LLC Portfolio

Follow Frontier Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Wealth Management LLC with notifications on news.